Evidence map›Paper›PMID 39179918›Full record

ArticleCardiovascular and interventional radiology2024

Evaluation of Vessel Tracking Software for Prostatic Artery Embolization.

Peter Schott, Tiago Bilhim, Aaron Fischman, Paul Lohle, Patrick Freyhardt, Nuno Vasco Costa, Alexander Venmans, Marcus Katoh

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular and interventional radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. The Downside of Portal Vein Embolization: Is It Still Worth It?Cardiovascular and interventional radiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Peter SchottClinic for Diagnostic and Interventional Radiology, Helios Hospital Krefeld, Lutherplatz 40, 47805, Krefeld, Germany. peter.schott@helios-gesundheit.de.ORCID http://orcid.org/0000-0003-0156-4695
Tiago BilhimInterventional Radiology Unit, SAMS Hospital, Lisbon, Portugal.
Aaron FischmanDepartment of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Paul LohleDepartment of Radiology, Tweesteden Hospital, Tilburg, The Netherlands.
Patrick FreyhardtClinic for Diagnostic and Interventional Radiology, Helios Hospital Krefeld, Lutherplatz 40, 47805, Krefeld, Germany.
Nuno Vasco CostaDepartment of Radiology, Central University Hospital Lisbon, Lisbon, Portugal.
Alexander VenmansDepartment of Radiology, Tweesteden Hospital, Tilburg, The Netherlands.
Marcus KatohClinic for Diagnostic and Interventional Radiology, Helios Hospital Krefeld, Lutherplatz 40, 47805, Krefeld, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate Vessel Tracking software for determining the prostatic arteries feeding the prostate gland during prostatic artery embolization (PAE) using Conebeam-CT (CBCT). MATERIALS AND

methodsEmboGuide is a software developed to assist interventional radiologists in performing embolization of hypervascular tumors in the liver. In this study, a single-center retrospective image collection of 120 intraprocedural CBCT of 60 patients with benign prostatic hyperplasia treated using PAE between May 2017 and January 2019 was evaluated. All patients received 1 intraprocedural CBCT per side for evaluation of vessel anatomy. The "reference standard" of the vascular anatomy was defined by segmentation of the prostatic gland and marking of the prostatic artery in conjunction with pre-embolization DSA series. The datasets were then anonymized. Three interventional radiologists with experience in PAE from different centers reviewed the images and used the automatic feeder detection to determine the prostatic artery. Finally, two clinical experts compared the feeding vessels indicated in the "reference standard" and those identified by the readers. Objectives of the study were to evaluate the clinical performance of the software based on sensitivity and the agreement between interventional radiologists.

resultsSensitivity was estimated as 0.968 with a 90% confidence interval. Overall agreement was estimated as 0.801 with a 90% confidence interval. On both objectives (Sensitivity and Agreement), specifications were met.

conclusionsThe results of this study suggest that EmboGuide can be used to determine the prostate arteries in PAE. The findings could be used to expand the intended use of EmboGuide to include PAE.

Indexed as

Cone-Beam Computed TomographyEmbolization, TherapeuticProstateProstatic HyperplasiaSoftwareAgedAged, 80 and overArteriesHumansMaleMiddle AgedRadiography, InterventionalRetrospective StudiesCBCTConebeam-CTEmboGuideProstatic arteriesProstatic artery embolization (PAE)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.